Veradigm (NASDAQ:MDRX) Trading Up 10.9% – Time to Buy?

Veradigm Inc. (NASDAQ:MDRX)’s stock price was up 10.9% on Monday . The stock traded as high as $10.65 and last traded at $10.65. Approximately 11,507 shares traded hands during trading, a decline of 99% from the average daily volume of 1,610,281 shares. The stock had previously closed at $9.60.

Analyst Upgrades and Downgrades

Separately, StockNews.com assumed coverage on shares of Veradigm in a research note on Saturday. They issued a “hold” rating for the company. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $12.00.

Veradigm Trading Up 0.4 %

The company’s fifty day simple moving average is $9.54 and its 200-day simple moving average is $9.29.

Hedge Funds Weigh In On Veradigm

An institutional investor recently bought a new stake in Veradigm stock. Tyro Capital Management LLC purchased a new position in Veradigm Inc. (NASDAQ:MDRX) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 1,176,015 shares of the software maker’s stock, valued at approximately $9,055,000. Veradigm comprises approximately 5.2% of Tyro Capital Management LLC’s portfolio, making the stock its 10th largest position. Tyro Capital Management LLC owned 1.08% of Veradigm as of its most recent filing with the Securities and Exchange Commission (SEC).

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.